Stem cell agency unveils CIRM 2.0 and invests $24 million to create Alpha Clinic Network
The CIRM unveiled the Agency’s plans for CIRM 2.0, detailing an approach that would dramatically reduce the amount of time it takes to approve funding for a potential therapy heading into a clinical trial. The CIRM board also voted to award $24 million to set up three new clinical trial centers. October 23, 2014